Name: PAHC Income Statement - Phibro Animal Health Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

PAHC - Phibro Animal Health Corp.

USD | NASDAQ | Healthcare

PAHC Income Statement - Phibro Animal Health Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q3 FY 26	Q2 FY 26	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16
Revenues
Revenues	383.5	373.9	363.9	378.7	347.8	309.3	260.4	273.2	263.2	249.9	231.3	255.0	245.7	244.6	232.5	255.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012
Revenues
Revenues	1,500.0	1,296.2	1,017.7	977.9	942.3	833.4	800.4	828.0	820.0	764.3	751.5	748.6	691.9	653.2	654.1
Cost of Revenue	1,011.9	896.3	704.6	679.7	656.9	562.0	543.5	563.4	553.1	516.0	512.5	515.3	487.5	474.2	490.0
Gross Profit	488.1	399.9	313.1	298.2	285.4	271.4	256.9	264.6	266.9	248.2	239.0	233.3	204.4	179.0	164.1
Operating Expenses
Research & Development	-	23.7	29.2	24.4	20.8	17.8	13.7	12.1	10.0	9.4	11.0	9.5	8.2	6.6	7.2
Operating Income
Operating Income	180.0	110.5	53.3	71.8	79.0	74.9	69.2	83.2	98.9	97.9	85.7	87.7	63.8	56.7
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	0.1	0.1	0.3
Tax & Net
Income Tax Expense	33.6	19.7	8.5	21.5	23.2	12.1	22.0	16.8	23.2	15.9	(6.0)	18.5	9.4	(7.0)	6.1
Per Share
EPS Basic	2.35	1.19	0.06	0.81	1.21	1.34	0.83	1.35	1.61	1.63	2.11	1.55	(0.10)	0.82	-
EPS Diluted
Supplementary Data
EBITDA	230.5	156.1	89.5	105.9	111.7	106.8	101.5	110.8	125.9	123.9	109.2	109.3	85.2	75.8	66.9
EBIT

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling General & Administrative	81.0	82.3	68.5	76.3	71.1	76.3	65.8	68.7	59.7	62.9	68.5	52.9	57.0	61.5	55.0	55.5
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	12.4	12.9	12.8	12.4	12.6	11.6	9.0	9.2	9.2	8.9	8.9	8.6	8.5	8.5	8.5	8.4
Amortization of Intangibles	1.7	1.7	1.7	1.7	1.7	2.2	2.3	2.3	2.4	2.5	2.4	2.4	2.4	2.4	2.4	2.4	2.2
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Operating Income
Operating Income	44.7	50.3	51.3	33.7	33.5	25.5	17.7	18.4	19.9	15.7	(0.7)	23.8	18.6	15.8	13.7	22.9	19.2	22.3	14.6	19.2	20.1	19.9	15.7	18.1	21.3	19.6	10.1	12.1	22.6	25.7	22.9	26.1	26.5	23.9	22.4	23.5	30.0	22.6	21.8	20.1

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	10.7	12.5	12.5	9.0	9.7	9.8	8.8	6.0	5.6	5.7	5.6	5.4	4.9	4.6	3.7	3.4	3.1	3.1
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	32.3	36.4	36.3	23.8	29.7	4.8	9.6	6.4	12.9	3.6	(12.0)	21.4	15.1	12.1	5.4	12.4	26.8

Per Share
EPS Basic	0.59	0.68	0.65	-	0.52	0.08	0.17	-	0.21	0.03	(0.20)	-	0.25	0.18	0.10	-	0.44	0.43	0.16	-	0.30	0.32	0.30	-	0.33	0.29	0.06	-	0.37	0.37	0.40	-	0.49	0.17	0.40	-	0.60	0.34	0.31	-
EPS Diluted	0.59	0.67	0.65	-	0.51	0.08	0.17	-	0.21	0.03	(0.20)	-	0.25	0.18	0.10	-	0.44	0.43
Shares Basic	40.6	40.5	40.5	-	40.5	40.5	40.5	-	40.5	40.5	40.5	-	40.5	40.5	40.5	-	40.5	40.5
Shares Diluted	41.0	41.0	40.9	-	40.7	40.7	40.6	-	40.5	40.5	40.5	-	40.5	40.5	40.5	-	40.5	40.5

Supplementary Data
EBITDA	57.1	63.2	64.1	46.1	46.1	37.1	26.7	27.6	29.1	24.6	8.1	32.3	27.0	24.3	22.1	31.3	27.6	30.3	22.5	27.0	28.1	28.0	23.7	26.3	29.6	27.8	17.9	19.3	29.4	32.5	29.5	33.0	33.2	30.6	29.0	29.9	36.8	29.1	28.1	26.9
EBIT	44.7	50.3	51.3	33.7	33.5	25.5	17.7	18.4	19.9	15.7	(0.7)	23.8	18.6	15.8	13.7	22.9	19.2	22.3	14.6

Tax & Net
Income Tax Expense	8.3	9.0	9.7	6.6	8.8	1.7	2.6	5.7	4.5	2.3	(4.0)	9.9	5.1	4.9	1.6	4.9	9.1	6.1	3.1	(1.0)	5.6	3.3	4.2	10.7	5.2	5.0	1.1	0.4	4.7	5.3	6.4	1.4	4.5	14.2	3.1	1.8	2.8	5.9	5.4	2.8
Net Income From Continuing Ops	24.0	27.5	26.5	17.2	20.9	3.2	7.0	0.8	8.4	1.3	(8.0)	11.5	10.0	7.2	3.9	7.5	17.7
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	24.0	27.5	26.5	17.2	20.9	3.2	7.0	0.8	8.4	1.3	(8.0)	11.5	10.0	7.2	3.9	7.5	17.7
Net Income Attributable To Parent	24.0	27.5	26.5	17.2	20.9	3.2	7.0	0.8	8.4	1.3	(8.0)	11.5	10.0	7.2	3.9	7.5
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	24.0	27.5	26.5	17.2	20.9	3.2	7.0	0.8	8.4	1.3	(8.0)	11.5	10.0	7.2	3.9